Originally published November 4 2005
Harvard chemist uses nanotechnology to detect cancer
by Mike Adams, the Health Ranger, NaturalNews Editor
Charles Lieber, a chemist at Harvard University, believes that his device, a detector that senses multiple cancer markers using nanowires, could lead to the first at-home cancer screening test.
Biomedical researchers have been discovering more and more proteins that reveal the presence of a cancer before its symptoms appear -- and while its treatment success rate is still high.
Yet turning these findings into quick, accurate, and inexpensive diagnostic tests has proven difficult.
In an article this month in Nature Biotechnology, he announced a highly-sensitive detector that can simultaneously find multiple cancer markers.
According to Lieber, the device, which uses nanowires to detect telltale cancer proteins, could lead to inexpensive and highly-accurate tests -- people could even buy them in a local drugstore and perform the testing themselves.
"We can take a very small amount of blood and with a very simple filtration step get an answer within five minutes," Lieber says, adding that the device has "a sensitivity a thousand times better" than in a lab.
Lieber's prototype builds on what University of California, Berkeley chemistry professor Paul Alivisatos has called "a breakthrough series of experiments."
To detect specific cancer markers, Lieber attached a monoclonal antibody specific for a certain type of protein to nanowires each about as narrow as a virus.
Some earlier experiments showed that changes in the conductivity of nanowires occurs when proteins bind to an antibody.
The more proteins that bind, the more the conductivity changes, revealing the concentration of the protein.
In his latest device, Lieber combined multiple nanowire detectors, each primed to be sensitive to a different cancer marker.
The resulting ability to detect more than one marker is key because cancers vary.
"The bottom line is no single marker, as a general rule, has had the sensitivity to be able to be used as a definitive marker," says David Sidransky, a cancer specialist at Johns Hopkins Medical Institutions.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml